W. J. Weiss

Publication List Details

Period

1995 - 2006

Number

15

Co-Authors

Technical Issues Related to the Use of Fly Ash and Slag During Late-Fall (Low Temperature) Construction Season (2006)

Krishnan, Anand, Mehta, Jinesh K., Olek, Jan, Weiss, W. J.

The potential for scaling of concrete pavement containing fly ash is one of the durability concerns which imposes restrictions on the use of fly ash in paving applications in Indiana during the...

ANALYSIS OF AN ADVANCED TIME-FREQUENCY NATIONAL AIR SPACE SYSTEM CONCEPT. VOLUME I. SUMMARY. (2005)

Weiss,W. J., Shapiro,L., Caldwell,R. W., Hagerott,R. E., Roth,M. F.

An Advanced National Airspace System concept meeting safety and traffic handling capacity requirements of the post-1980 era is described. This distributed sensor and closed-loop control system...

Susceptibility of enterococci, methicillin-resistant Staphylococcus aureus and Streptococcus pneumoniae to the glycylcyclines (1995)

Weiss, W. J., Jacobus, N. V., Petersen, P. J., Testa, Raymond T.

The in-vitro activities of two glycylcyclines, DMG-MINO and DMG-DMDOT, and several comparative agents were determined against 263 enterococci, 102 methicillin-resistant Staphylococcus aureus and 55...

In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9-t-Butylglycylamido Derivative of Minocycline (GAR-936)

Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum, P. E., Testa, R. T.

The 9-t-butylglycylamido derivative of minocycline (TBG-MINO) is a recently synthesized member of a novel group of antibiotics, the glycylcyclines. This new derivative, like the first glycylcyclines,...

In Vivo Pharmacodynamic Activities of Two Glycylcyclines (GAR-936 and WAY 152,288) against Various Gram-Positive and Gram-Negative Bacteria

Van Ogtrop, M. L., Andes, D., Stamstad, T. J., Conklin, B., Weiss, W. J., Craig, W. A., ...

The in vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) were assessed in an experimental murine thigh infection model in neutropenic mice. Mice were infected with one...

Saccharomicins, Novel Heptadecaglycoside Antibiotics Produced by Saccharothrix espanaensis: Antibacterial and Mechanistic Activities

Singh, M. P., Petersen, P. J., Weiss, W. J., Kong, F., Greenstein, M.

Saccharomicins A and B, two new heptadecaglycoside antibiotics, were isolated from the fermentation broth of the rare actinomycete Saccharothrix espanaensis. They represent a novel class of...

Mannopeptimycins, New Cyclic Glycopeptide Antibiotics Produced by Streptomyces hygroscopicus LL-AC98: Antibacterial and Mechanistic Activities

Singh, M. P., Petersen, P. J., Weiss, W. J., Janso, J. E., Luckman, S. W., Lenoy, E. B., ...

Mannopeptimycins α, β, γ, δ, and ɛ are new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98. Mannopeptimycins γ, δ, and ɛ, which have an isovaleryl substitution...

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.

Kuck, N A, Jacobus, N V, Petersen, P J, Weiss, W J, Testa, R T

Tazobactam (YTR-830H), a novel beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam for enhancement of the activity of piperacillin against beta-lactamase-producing,...

In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.

Petersen, P J, Jacobus, N V, Weiss, W J, Testa, R T

The activity of LJC10,627 was compared with the activities of imipenem and other antibiotics. LJC10,627 was more active against most members of the family Enterobacteriaceae, Pseudomonas spp., and...

In Vitro and In Vivo Antibacterial Activities of a Novel Glycylcycline, the 9-t-Butylglycylamido Derivative of Minocycline (GAR-936)

Petersen, P. J., Jacobus, N. V., Weiss, W. J., Sum, P. E., Testa, R. T.

The 9-t-butylglycylamido derivative of minocycline (TBG-MINO) is a recently synthesized member of a novel group of antibiotics, the glycylcyclines. This new derivative, like the first glycylcyclines,...

In Vivo Pharmacodynamic Activities of Two Glycylcyclines (GAR-936 and WAY 152,288) against Various Gram-Positive and Gram-Negative Bacteria

Van Ogtrop, M. L., Andes, D., Stamstad, T. J., Conklin, B., Weiss, W. J., Craig, W. A., ...

The in vivo pharmacodynamic activities of two glycylcyclines (GAR-936 and WAY 152,288) were assessed in an experimental murine thigh infection model in neutropenic mice. Mice were infected with one...

Saccharomicins, Novel Heptadecaglycoside Antibiotics Produced by Saccharothrix espanaensis: Antibacterial and Mechanistic Activities

Singh, M. P., Petersen, P. J., Weiss, W. J., Kong, F., Greenstein, M.

Saccharomicins A and B, two new heptadecaglycoside antibiotics, were isolated from the fermentation broth of the rare actinomycete Saccharothrix espanaensis. They represent a novel class of...

Mannopeptimycins, New Cyclic Glycopeptide Antibiotics Produced by Streptomyces hygroscopicus LL-AC98: Antibacterial and Mechanistic Activities

Singh, M. P., Petersen, P. J., Weiss, W. J., Janso, J. E., Luckman, S. W., Lenoy, E. B., ...

Mannopeptimycins α, β, γ, δ, and ɛ are new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98. Mannopeptimycins γ, δ, and ɛ, which have an isovaleryl substitution...

Comparative in vitro and in vivo activities of piperacillin combined with the beta-lactamase inhibitors tazobactam, clavulanic acid, and sulbactam.

Kuck, N A, Jacobus, N V, Petersen, P J, Weiss, W J, Testa, R T

Tazobactam (YTR-830H), a novel beta-lactamase inhibitor, was compared with clavulanic acid and sulbactam for enhancement of the activity of piperacillin against beta-lactamase-producing,...

In vitro and in vivo activities of LJC10,627, a new carbapenem with stability to dehydropeptidase I.

Petersen, P J, Jacobus, N V, Weiss, W J, Testa, R T

The activity of LJC10,627 was compared with the activities of imipenem and other antibiotics. LJC10,627 was more active against most members of the family Enterobacteriaceae, Pseudomonas spp., and...